N/A
N=119
Development & Pilot of the Technology-Enabled Alliance for Medication Therapy Management
Polypharmacy
Bottom Line
View on ClinicalTrials.gov: NCT04575155 ↗Enrolled (actual)
119
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Medication Reconciliation — 0.14; 0.17 number of discrepancies per medication
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- TEAM Strategy (Behavioral)
- Age
- Adult, Older Adult · 50+ yrs
- Sex
- All
- Sponsor
- Northwestern University
- Primary completion
- Oct 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Medication Reconciliation |
0.14; 0.17 | — |
Summary
The investigators will link community pharmacy and primary care practices via a shared electronic health record to improve medication therapy management for older patients taking complex prescription (Rx) regimens. The Technology-Enabled Alliance for Medication Therapy Management (TEAM) intervention will link a major, national community pharmacy chain (Walgreens) to primary care practices (Access Community Health Network) via a shared electronic health record (EHR) platform (Epic, Verona WI). Through shared access to patients' medical records, pharmacists can perform comprehensive medication therapy management services, document and communicate patients' Rx challenges for review and action by primary care providers. The aims of this investigation are to:
1. Evaluate the fidelity and efficacy of the TEAM intervention to promote healthcare provider counseling, medication reconciliation, and safe regimen use among adults taking complex Rx regimens.
2. Explore patient, healthcare provider (pharmacist, prescriber), community pharmacy and/or primary care practice barriers to implementation.
3. Determine the costs of the TEAM intervention from both a community pharmacy and primary care practice perspective.
Eligibility Criteria
- Patient is age 50 and older
- Patient is English or Spanish speaking
- Patient has established care at one of the involved ACCESS health centers (defined as 1 visit within 18 months)
- Patient is an existing Walgreens customer (had 1 or more medications filled at collocated Walgreens pharmacy within past 12 months)
- Patient is currently prescribed 5 or more Rx medications (excluding antibiotics); that includes at least one medication from any of the following six therapeutic classes of medications: hyperlipidemia, hypertension, diabetes, multiple sclerosis, hepatitis C, and HIV
- Patient is primarily responsible for administering own medication
Exclusion Criteria
- Severe, uncorrectable vision
- Hearing impairments
- Cognitive impairment (as measured by the 6-item screener)
Data sourced from ClinicalTrials.gov (NCT04575155). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.